Cementless total hip replacements in sickle cell disease

Christopher M Jack1, Jo Howard1, Emad S Aziz1

  • 1University Hospital Southampton, Southampton, Hampshire - UK.

Insights

Uncemented total hip arthroplasty (THA) with ceramic-on-ceramic bearings is a safe and reliable option for sickle cell disease (SCD) patients, showing no implant loosening or osteolysis in a 5-year follow-up.

Area of Science:

  • Orthopedic Surgery
  • Biomaterials Science
  • Hematology

Background:

  • Sickle cell disease (SCD) impacts numerous individuals, with a high incidence of femoral head osteonecrosis.
  • Cemented acetabular components demonstrate suboptimal outcomes in SCD patients, marked by significant osteolysis rates.
  • Uncemented total hip arthroplasty (THA) with ceramic-on-ceramic (CoC) bearings presents an alternative approach.

Purpose of the Study:

  • To evaluate the efficacy and safety of uncemented THA using CoC bearings in patients with SCD.
  • To assess the long-term outcomes, including osteolysis, migration, and loosening, of these implants.

Main Methods:

  • A cohort of 40 SCD patients underwent 52 primary THAs between 2002 and the present.
  • Preoperative blood transfusions were administered to most patients.
  • Uncemented implants (S-ROM, Solutions, AML) were utilized, with some cases requiring femoral drilling.

Main Results:

  • All uncemented components achieved osseointegration.
  • No instances of radiographic osteolysis, migration, or loosening were observed.
  • The average follow-up period was 5 years, ranging from 2 to 10.1 years.

Conclusions:

  • Uncemented THA with CoC bearings is a safe and effective procedure for SCD patients.
  • A multidisciplinary team approach is crucial for successful outcomes.
  • This approach minimizes complications like osteolysis and implant failure.
Abstract

Related Concept Videos